InvestorsHub Logo
Followers 31
Posts 6445
Boards Moderated 0
Alias Born 01/20/2016

Re: None

Thursday, 05/04/2023 8:18:35 AM

Thursday, May 04, 2023 8:18:35 AM

Post# of 462881
Quote from TGD when asked a question at recent MSQVentures Conference !!!!------"Answer: The clinical trials have shown that patients with significant Alzheimer's disease who received ANAVEX®2-73 actually reversed their cognitive impairment and improved their activities of daily living, rather than just slowing the decline. This is an exciting result that shows the potential for patients to change the course of their disease pathology. To be enrolled in the trial, patients must have confirmed Alzheimer's pathology, Parkinson's pathology, Parkinson's dementia, or a genetic mutation for Red Syndrome. The confirmation of their disease is necessary before starting the trial."-- Awesome--what not to like ????

msqventures.com/msq-ceo-web...
Show More
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News